Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42360c31a603174257cc04862aac20e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_283c3294b52dc7ec6b88039fbc7be613 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-24 |
filingDate |
2011-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ee14bfaa6367d6b39884b5e7af8fbde |
publicationDate |
2016-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9242958-B2 |
titleOfInvention |
Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
abstract |
The new pyridazine derivatives have unexpected drug properties as inhibitors of protein kinases especially against c-Met and are useful in treating disorders related to abnormal protein kinase activities such as cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016068493-A1 |
priorityDate |
2010-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |